import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰åœ–æ›¸é¤¨ (2026 æœ€çµ‚å…¨åŠŸèƒ½æ•´åˆç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
Â  Â  <style>
Â  Â  @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
Â  Â Â 
Â  Â  /* === æ¥µè‡´ç·Šç·»åŒ– UI èˆ‡ é«˜å°æ¯”åº¦æ–‡å­— === */
Â  Â  html, body, [class*="css"] {
Â  Â  Â  Â  font-family: 'Noto Sans TC', 'Roboto', sans-serif;
Â  Â  Â  Â  background-color: #F4F7F9;
Â  Â  Â  Â  color: #1A1A1A;
Â  Â  Â  Â  font-size: 19px !important;
Â  Â  Â  Â  line-height: 1.1;
Â  Â  }

Â  Â  .main-title {
Â  Â  Â  Â  font-size: 32px !important; font-weight: 900; color: #004D40;
Â  Â  Â  Â  padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
Â  Â  }

Â  Â  /* å¤§éšæ®µæ–¹å¡Šï¼šé›¶ç•™ç™½è¨­è¨ˆ */
Â  Â  .big-stage-card {
Â  Â  Â  Â  border-radius: 10px; padding: 0px;Â 
Â  Â  Â  Â  box-shadow: 0 2px 10px rgba(0,0,0,0.08);
Â  Â  Â  Â  border: 2px solid transparent; background: white;Â 
Â  Â  Â  Â  margin-bottom: 4px; overflow: hidden; height: auto !important;
Â  Â  }
Â  Â  .big-stage-header {
Â  Â  Â  Â  font-size: 17px !important; font-weight: 900; color: white;
Â  Â  Â  Â  padding: 5px; text-align: center;
Â  Â  }

Â  Â  /* å­å€å¡Š (SoC èˆ‡åˆ†å­äºå‹) */
Â  Â  .sub-block {
Â  Â  Â  Â  margin: 2px 4px; padding: 4px;
Â  Â  Â  Â  border-radius: 6px; background: #F8F9FA;
Â  Â  Â  Â  border-left: 5px solid #546E7A;
Â  Â  }
Â  Â  .sub-block-title {
Â  Â  Â  Â  font-size: 13px; font-weight: 900; color: #37474F;
Â  Â  Â  Â  margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
Â  Â  }
Â  Â  .sub-block-content {
Â  Â  Â  Â  font-size: 14px; color: #263238; font-weight: 500; line-height: 1.15;
Â  Â  }

Â  Â  /* éšæ®µé…è‰² */
Â  Â  .card-p-tx { border-color: #2E7D32; }
Â  Â  .header-p-tx { background: linear-gradient(135deg, #43A047, #2E7D32); }
Â  Â  .card-p-mt { border-color: #1565C0; }
Â  Â  .header-p-mt { background: linear-gradient(135deg, #1E88E5, #1565C0); }
Â  Â  .card-r-tx { border-color: #E65100; }
Â  Â  .header-r-tx { background: linear-gradient(135deg, #FB8C00, #E65100); }
Â  Â  .card-r-mt { border-color: #6A1B9A; }
Â  Â  .header-r-mt { background: linear-gradient(135deg, #8E24AA, #6A1B9A); }

Â  Â  /* æŒ‰éˆ•æ¨£å¼ï¼šæ·±é»‘è‰²åŠ ç²— (#1A1A1A) */
Â  Â  .stPopover button {Â 
Â  Â  Â  Â  font-weight: 900 !important; font-size: 11px !important;Â 
Â  Â  Â  Â  border-radius: 4px !important; margin-top: 1px !important;
Â  Â  Â  Â  padding: 1px 6px !important; width: 100% !important;Â 
Â  Â  Â  Â  text-align: left !important; color: #1A1A1A !important;Â 
Â  Â  Â  Â  border: 1px solid rgba(0,0,0,0.15) !important;
Â  Â  Â  Â  box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
Â  Â  }
Â  Â Â 
Â  Â  .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }
Â  Â  .stPopover button[aria-label*="Eli Lilly"] { background: #FCE4EC !important; border-left: 5px solid #E91E63 !important; }Â 
Â  Â  .stPopover button[aria-label*="Daiichi Sankyo"] { background: #E8F5E9 !important; border-left: 5px solid #4CAF50 !important; }Â 
Â  Â  .stPopover button[aria-label*="MSD"] { background: #E3F2FD !important; border-left: 5px solid #1976D2 !important; }Â 
Â  Â  .stPopover button[aria-label*="AstraZeneca"] { background: #F3E5F5 !important; border-left: 5px solid #8E24AA !important; }Â 
Â  Â  .stPopover button[aria-label*="GSK"] { background: #FFF3E0 !important; border-left: 5px solid #F57C00 !important; }Â 
Â  Â  .stPopover button[aria-label*="Gilead"] { background: #E1F5FE !important; border-left: 5px solid #03A9F4 !important; }Â 
Â  Â  .stPopover button[aria-label*="Seagen"] { background: #EEEEEE !important; border-left: 5px solid #212121 !important; }Â 

Â  Â  .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
Â  Â  .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 45px !important; font-weight: 900; color: #D84315; }
Â  Â  </style>
Â  Â  """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å°èˆªæ•¸æ“šåº«ï¼šåŒ…å« MOC é‘‘åˆ¥èˆ‡ PSOC/PROC åˆ†æµ ---
guidelines_nested = {
Â  Â  "Endometrial": [
Â  Â  Â  Â  {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
Â  Â  Â  Â  Â  Â  {"title": "MMRd / MSI-H / dMMR", "content": "ä¸€ç·šæ¨™ç«¿ï¼šChemo + PD-1 (GY018/RUBY)ã€‚Dostarlimab ç²ç›Šæ¥µé¡¯è‘—ã€‚"},
Â  Â  Â  Â  Â  Â  {"title": "NSMP / pMMR / MSS", "content": "æ’é™¤åˆ†å‹ã€‚è¦– ER/Grade æ¬Šé‡æ±ºç­–ï¼›äºŒç·šè€ƒæ…® Pembro+Lenvaã€‚"},
Â  Â  Â  Â  Â  Â  {"title": "POLEmut / p53abn", "content": "POLE: æœ€ä½³é å¾Œï¼›p53abn: æœ€å·®é å¾Œï¼Œéœ€ç©æ¥µè¼”åŠ©æ²»ç™‚ã€‚"}]},
Â  Â  Â  Â  {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "ä¸€ç·š IO æ²»ç™‚å¾Œæ¥çºŒç¶­æŒç›´åˆ°ç–¾ç—…é€²å±• (PD)ã€‚"}]},
Â  Â  Â  Â  {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "Recurrent EC", "content": "äºŒç·šæ–¹æ¡ˆï¼šæ¨™é¶+å…ç–« (pMMR) æˆ– IO å–®è—¥ (MMRd/GARNET)ã€‚"}]},
Â  Â  Â  Â  {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ°ä¸å¯è€å—æˆ–é€²å±•ã€‚"}]}
Â  Â  ],
Â  Â  "Ovarian": [
Â  Â  Â  Â  {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
Â  Â  Â  Â  Â  Â  {"title": "HGSC / Endometrioid", "content": "æ‰‹è¡“ (PDS/IDS) + Carboplatin/Paclitaxel Â± Bevacizumabã€‚"},
Â  Â  Â  Â  Â  Â  {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "åˆ¤å®šï¼šCK7+/SATB2- (åŸç™¼)ã€‚1. Expansile: é å¾Œä½³ã€‚ 2. Infiltrative: é«˜å¾©ç™¼é¢¨éšªï¼Œå»ºè­°ç©æ¥µåŒ–ç™‚ã€‚"}]},
Â  Â  Â  Â  {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
Â  Â  Â  Â  Â  Â  {"title": "BRCA mutated", "content": "Olaparib å–®è—¥ç¶­æŒ 2å¹´ã€‚"}, {"title": "HRD positive (wt)", "content": "Olaparib+Bev (2å¹´) æˆ– Niraparib å–®è—¥ (3å¹´)ã€‚"}]},
Â  Â  Â  Â  {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (R-TX)", "css": "r-tx", "subs": [
Â  Â  Â  Â  Â  Â  {"title": "PSOC (Sensitive)", "content": "PFI > 6mã€‚å«é‰‘é›™è—¥åŒ–ç™‚ Â± Bevã€‚è©•ä¼°äºŒæ¬¡æ‰‹è¡“ (DESKTOP)ã€‚"},
Â  Â  Â  Â  Â  Â  {"title": "PROC (Resistant)", "content": "PFI < 6mã€‚å–®è—¥åŒ–ç™‚ Â± Bev æˆ–æ¨™é¶ ADC (MIRASOL/FRAmework)ã€‚"}]},
Â  Â  Â  Â  {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive Maint", "content": "æ•‘æ´ç·©è§£å¾ŒçºŒä»¥ PARPi ç¶­æŒæ²»ç™‚ã€‚"}]}
Â  Â  ],
Â  Â  "Cervical": [
Â  Â  Â  Â  {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
Â  Â  Â  Â  Â  Â  {"title": "CCRT (Locally Advanced)", "content": "åŒæ­¥åŒ–æ”¾ç™‚ã€‚é«˜é¢¨éšªè€…åŒæ­¥ IO (A18) æˆ–èª˜å°åŒ–ç™‚ (INTERLACE)ã€‚"},
Â  Â  Â  Â  Â  Â  {"title": "Early Stage (Surgery)", "content": "æ ¹æ²»æ€§é–‹è…¹è¡“ (LACC)ã€‚ä½é¢¨éšªè€…é¸å–®ç´”åˆ‡é™¤ (SHAPE)ã€‚"}]},
Â  Â  Â  Â  {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Metastatic Maint", "content": "1L è½‰ç§»æ€§ IO æ–¹æ¡ˆå¾Œå»¶çºŒç¶­æŒè‡³é€²å±•ã€‚"}]},
Â  Â  Â  Â  {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
Â  Â  Â  Â  Â  Â  {"title": "Recurrent / Metastatic", "content": "ä¸€ç·š Pembro + åŒ–ç™‚ Â± Bevã€‚äºŒç·š ADC (Tivdak) æˆ– IO (EMPOWER)ã€‚"}]},
Â  Â  Â  Â  {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´è‡³é€²å±•ã€‚"}]}
Â  Â  ]
}

# --- 2. å¯¦è­‰é‡Œç¨‹ç¢‘ (ğŸ“š Milestone Library - å®Œæ•´ 24 é …æ·±åº¦å°æ‡‰) ---
milestone_db = [
Â  Â  # Endometrial
Â  Â  {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H / dMMR"], "name": "ğŸ“š RUBY", "drug": "Dostarlimab + CP", "summary": "FIGO III-IV/Recurrentã€‚dMMR æ­»äº¡é¢¨éšªé™ 68% (HR 0.32)ï¼›å…¨äººç¾¤ mOS 44.6m vs 28.2m (HR 0.69)ã€‚"},
Â  Â  {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H / dMMR", "NSMP / pMMR / MSS"], "name": "ğŸ“š NRG-GY018", "drug": "Pembrolizumab + CP", "summary": "FIGO III-IV/Recurrentã€‚dMMR PFS HR 0.30ï¼›pMMR äº¦é¡¯è‘—æ”¹å–„ (HR 0.54)ã€‚æ”¯æŒä¸€ç·šä¸è«– MMR ä¹‹ IO ç²ç›Šã€‚"},
Â  Â  {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["NSMP / pMMR / MSS"], "name": "ğŸ“š DUO-E", "drug": "Durvalumab Â± Olaparib", "summary": "ä¸€ç·šæ™šæœŸã€‚ä¸‰è—¥çµ„ PFS HR 0.57 (vs CP)ï¼›Durva çµ„ HR 0.77ã€‚å»ºç«‹å…ç–«ç¶­æŒç­–ç•¥ã€‚"},
Â  Â  {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H / dMMR"], "name": "ğŸ“š AtTEnd", "drug": "Atezolizumab + CP", "summary": "ä¸€ç·šæ™šæœŸã€‚dMMR PFS HR 0.36ï¼Œç²ç›Šæ¥µå¤§ï¼›å…¨é«” OS HR 0.82ã€‚æ”¯æŒ PD-(L)1 ä½µåŒ–ç™‚è­‰æ“šéˆã€‚"},
Â  Â  {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š KEYNOTE-775", "drug": "Lenvatinib + Pembro", "summary": "äºŒç·š(æ›¾å«é‰‘)ã€‚pMMR OS 17.4m vs 12.0m (HR 0.68)ï¼›5å¹´ OS 16.7% vs 7.3%ã€‚MSS äºŒç·šæ¨™æº–ã€‚"},

Â  Â  # Cervical
Â  Â  {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["CCRT (Locally Advanced)"], "name": "ğŸ“š KEYNOTE-A18", "drug": "Pembrolizumab + CCRT", "summary": "é«˜é¢¨éšª LACCã€‚36å€‹æœˆ OS 82.6% vs 74.8% (HR 0.67)ã€‚ç¢ºç«‹åŒæ­¥å…ç–«æ¨™æº–ã€‚"},
Â  Â  {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["CCRT (Locally Advanced)"], "name": "ğŸ“š INTERLACE", "drug": "Induction Carbo/Pacli", "summary": "å±€éƒ¨æ™šæœŸã€‚6é€±èª˜å°åŒ–ç™‚å¾Œæ¥ CCRTï¼Œ5å¹´ OS 80% vs 72% (HR 0.60)ã€‚ç¾æˆåŒ–ç™‚å¯æå‡ç”Ÿå­˜ã€‚"},
Â  Â  {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["CCRT (Locally Advanced)"], "name": "ğŸ“š CALLA (é™°æ€§)", "drug": "Durvalumab + CCRT", "summary": "å±€éƒ¨æ™šæœŸã€‚æ•´é«”æœªé”çµ±è¨ˆå­¸ PFS æ”¹å–„ã€‚HR 0.84ã€‚æç¤ºéœ€æ›´ç²¾æº–åˆ†æµã€‚"},
Â  Â  {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurrent / Metastatic"], "name": "ğŸ“š KEYNOTE-826", "drug": "Pembro + Chemo Â± Bev", "summary": "R/M ä¸€ç·šã€‚å…¨äººç¾¤ OS HR 0.63ï¼›CPSâ‰¥1 HR 0.60ã€‚å¥ å®š R/M ä¸€ç·š IO åŸºç¤ã€‚"},
Â  Â  {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurrent / Metastatic"], "name": "ğŸ“š BEATcc", "drug": "Atezolizumab + Chemo+Bev", "summary": "R/M ä¸€ç·šã€‚PFS HR 0.62ï¼ŒOS HR 0.68ã€‚æä¾›ä¸€ç·šå…ç–«ä½µç”¨æ–°é¸é …ã€‚"},
Â  Â  {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurrent / Metastatic"], "name": "ğŸ“š EMPOWER-Cx 1", "drug": "Cemiplimab", "summary": "äºŒç·šã€‚OS 12.0m vs 8.5m (HR 0.69)ï¼›ç²ç›Šä¸ä¾è³´ PD-L1 è¡¨ç¾ã€‚å¾Œç·š IO å–®è—¥è­‰æ“šã€‚"},
Â  Â  {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurrent / Metastatic"], "name": "ğŸ“š innovaTV 301", "drug": "Tisotumab Vedotin", "summary": "äºŒ/ä¸‰ç·šã€‚OS 11.5m vs 9.5m (HR 0.70)ï¼ŒORR 17.8%ã€‚ADC é€²å…¥æ¨™æº–å¾Œç·šã€‚"},
Â  Â  {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early Stage (Surgery)"], "name": "ğŸ“š SHAPE trial", "drug": "Simple Hysterectomy", "summary": "æ—©æœŸä½é¢¨éšª(<2cm)ã€‚3å¹´å¾©ç™¼ç‡ 2.5% (SH) vs 2.2% (RH)ã€‚æ”¯æŒæ‰‹è¡“é™éšã€‚"},

Â  Â  # Ovarian
Â  Â  {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutated"], "name": "ğŸ“š SOLO-1", "drug": "Olaparib", "summary": "ä¸€ç·šç¶­æŒã€‚7å¹´ survival 67% (vs 46.5%, HR 0.33)ã€‚ç¢ºç«‹æ²»ç™’æ½›åŠ›é‡Œç¨‹ç¢‘ã€‚"},
Â  Â  {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š PAOLA-1", "drug": "Olaparib + Bevacizumab", "summary": "ä¸€ç·šç¶­æŒã€‚HRD+ æ—ç¾¤ 5å¹´ OS é¡¯è‘—æ”¹å–„ (HR 0.62)ã€‚ç¢ºç«‹ã€ŒPARPi + anti-VEGFã€è·¯å¾‘ã€‚"},
Â  Â  {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)", "HRD negative / pHRD"], "name": "ğŸ“š ATHENAâ€“MONO", "drug": "Rucaparib", "summary": "ä¸€ç·šç¶­æŒã€‚ITT PFS HR 0.52 (28.7m vs 11.3m)ï¼›æ”¯æŒå»£æ³› PARPi æ‡‰ç”¨ã€‚"},
Â  Â  {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š NOVA", "drug": "Niraparib", "summary": "å¾©ç™¼ç¶­æŒã€‚gBRCA HR 0.27ï¼›é gBRCA HR 0.45ã€‚é¡¯è‘—å»¶ç·©å¾©ç™¼ã€‚"},
Â  Â  {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š ARIEL3", "drug": "Rucaparib", "summary": "å¾©ç™¼ç¶­æŒã€‚Rucaparib åœ¨æ‰€æœ‰åˆ†å±¤(BRCA/HRD+/ITT)å‡ PFS æ”¹å–„ã€‚"},
Â  Â  {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š SOLO2", "drug": "Olaparib", "summary": "å¾©ç™¼ç¶­æŒ(BRCA)ã€‚OS 51.7m vs 38.8m (HR 0.74)ã€‚é•·æœŸç”Ÿå­˜ç²ç›Šé¡¯è‘—ã€‚"},
Â  Â  {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š DUO-O", "drug": "Durva+Ola+Bev", "summary": "ä¸€ç·šã€‚HRD+ çµ„ PFS é¡¯è‘—ç²ç›Š (HR 0.49)ã€‚IO çµ„åˆç­–ç•¥æ›´å…·æ½›åŠ›ã€‚"},
Â  Â  {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š LION (NEJM 2019)", "drug": "No Lymphadenectomy", "summary": "åˆæ²»æ‰‹è¡“ã€‚è‡¨åºŠ LN é™°æ€§è€…ï¼Œæ¸…æƒç„¡ç”Ÿå­˜ç²ç›Šä¸”ä½µç™¼ç—‡å¤šã€‚"},
]

# --- 3. é€²è¡Œä¸­è©¦é©— (ğŸ“ Ongoing - 8 æ ¸å¿ƒè©³ç›¡ç´°ç¯€) ---
ongoing_trials = [
Â  Â  {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"],Â 
Â  Â  Â "rationale": "æ¨™é¶ FRÎ± ADCã€‚è¯ç”¨ Bevacizumab å¯ç”¢ç”Ÿè¡€ç®¡èª¿ç¯€èˆ‡å…ç–«é‡å¡‘ä¹‹å”åŒä½œç”¨ (Synergy)ï¼Œæå‡ ADC æ»²é€æ·±åº¦ä¸¦é€éæ—è§€è€…æ•ˆæ‡‰æ®ºå‚·ä½è¡¨é”ç´°èƒï¼Œæ—¨åœ¨å…‹æœ PARPi è€è—¥å¾Œ PROC æ‚£è€…ä¹‹ Unmet Needsã€‚",
Â  Â  Â "dosing": "å¯¦é©—çµ„ï¼šLY4170156 3mg/kg IV + Bevacizumab 15mg/kg IV Q3Wã€‚å°ç…§çµ„ï¼šé†«å¸«é¸æ“‡å–®è—¥åŒ–ç™‚æˆ– MIRVã€‚",
Â  Â  Â "inclusion": ["çµ„ç¹”å­¸ HG Serous / Carcinosarcoma åµå·¢ç™Œã€‚", "ä¸­å¤®å¯¦é©—å®¤ç¢ºèª FRÎ± è¡¨é”é™½æ€§ã€‚", "æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©å…§æƒ¡åŒ– (PROC)ã€‚", "å…ˆå‰æ¥å—é 1â€“3 ç·šç³»çµ±æ²»ç™‚ã€‚"],
Â  Â  Â "exclusion": ["å…ˆå‰æ›¾ç”¨éå¸¶æœ‰ Topoisomerase I æŠ‘åˆ¶åŠ‘ Payload ä¹‹ ADC (å¦‚ Enhertu)ã€‚", "æ´»å‹•æ€§é–“è³ªæ€§è‚ºç—… (ILD) æˆ–è‚ºç‚ç—…å²ã€‚"], "ref": "NCT06536348"},
Â  Â Â 
Â  Â  {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd (Raludotatug Deruxtecan)", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"],Â 
Â  Â  Â "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCï¼Œæ­è¼‰å¼·æ•ˆ DXd è¼‰è·ã€‚å…·å‚™æ¥µé«˜ DAR (8) èˆ‡å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰ï¼Œå°ˆæ”»é«˜åº¦ç•°è³ªæ€§ä¹‹ PROC è…«ç˜¤ï¼Œè§£æ±ºå‚³çµ±åŒ–ç™‚åæ‡‰ç‡ä½è½ä¹‹ç“¶é ¸ã€‚",
Â  Â  Â "dosing": "å¯¦é©—çµ„ï¼šR-DXd 5.6mg/kg IV Q3Wã€‚å°ç…§çµ„ï¼šç ”ç©¶è€…é¸æ“‡å–®è—¥åŒ–ç™‚ (Pacli, PLD, or Topo)ã€‚",
Â  Â  Â "inclusion": ["çµ„ç¹”å­¸ HG Serous æˆ– Endometrioid PROCã€‚", "å…ˆå‰æ¥å— 1-4 ç·šç³»çµ±æ²»ç™‚ã€‚", "æä¾›ä¸­å¤®å¯¦é©—å®¤ CDH6 åˆ¤å®šåˆ†å±¤ã€‚", "éœ€æ›¾ç”¨é Bevacizumabã€‚"],
Â  Â  Â "exclusion": ["Low-grade / Clear cell / Mucinous (åŸç™¼)ã€‚", "åŸºç·š Grade â‰¥2 å‘¨é‚Šç¥ç¶“ç—…è®Šã€‚"], "ref": "JCO 2024"},
Â  Â Â 
Â  Â  {"cancer": "Ovarian", "name": "TroFuse-021", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD positive (wt)", "HRD negative / pHRD"],Â 
Â  Â  Â "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°ä¹‹å…ç–«åŸæ€§ç´°èƒæ­»äº¡ (ICD) æ•ˆæ‡‰ï¼Œå„ªåŒ– pHRD/HRD+ æ—ç¾¤åœ¨ä¸€ç·šå«é‰‘åŒ–ç™‚å¾Œç¶­æŒç²ç›Šã€‚",
Â  Â  Â "dosing": "å¯¦é©—è‡‚1ï¼šSac-TMT å–®è—¥ç¶­æŒã€‚å¯¦é©—è‡‚2ï¼šSac-TMT + Beva Q3Wã€‚å°ç…§è‡‚ï¼šStandard Bevacizumab ç¶­æŒã€‚",
Â  Â  Â "inclusion": ["æ–°è¨ºæ–· FIGO Stage III/IV åµå·¢ç™Œã€‚", "HRD ç‹€æ…‹ç”±ä¸­å¤®åˆ¤å®šã€‚", "ä¸€ç·šå«é‰‘åŒ–ç™‚å¾Œé” CR æˆ– PR ç‹€æ…‹ã€‚"],
Â  Â  Â "exclusion": ["BRCA çªè®Šã€‚", "å…ˆå‰ç”¨éé‡å° Trop-2 ä¹‹ ADC è—¥ç‰©ã€‚"], "ref": "ENGOT-ov85"},

Â  Â  {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembrolizumab", "pos": "P-MT", "sub_pos": ["IO Maintenance"],Â 
Â  Â  Â "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1 æŠ‘åˆ¶åŠ‘ã€‚é€éå…ç–«é‡å¡‘æå‡ Pembrolizumab åœ¨ pMMR æˆ– NSMP æ—ç¾¤çš„æ‡‰ç­”æ·±åº¦ã€‚",
Â  Â  Â "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)ã€‚", "FIGO III/IV ä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PRã€‚", "æœªé‡å°å¾©ç™¼é€²è¡Œéç³»çµ±æ€§æ²»ç™‚ã€‚"],
Â  Â  Â "exclusion": ["å­å®®è‚‰ç˜¤ (Sarcoma)ã€‚", "å…ˆå‰æ¥å—éé‡å°æ™šæœŸç—…ç¶ä¹‹ IO æ²»ç™‚ã€‚"], "ref": "ESMO 2025"},
Â  Â Â 
Â  Â  {"cancer": "Endometrial", "name": "GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["Recurrent EC"],Â 
Â  Â  Â "rationale": "æ¨™é¶ Trop-2 ADCã€‚åˆ©ç”¨ SN-38 è¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡èˆ‡å…ç–«å¤±æ•—æ•‘æ´ï¼Œå°æŠ—ç•°è³ªæ€§ç—…ç¶ã€‚",
Â  Â  Â "inclusion": ["å¾©ç™¼æ€§ EC (ä¸å«è‚‰ç˜¤)ã€‚", "é‰‘é¡èˆ‡ PD-1 å¤±æ•—å¾Œé€²å±•ã€‚", "å……åˆ†å™¨å®˜åŠŸèƒ½ (ANC â‰¥1500)ã€‚"],
Â  Â  Â "exclusion": ["å…ˆå‰ç”¨é Trop-2 ADCã€‚", "æ´»å‹•æ€§ CNS è½‰ç§»ã€‚"], "ref": "JCO 2024"},

Â  Â  {"cancer": "Ovarian", "name": "DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd (Trastuzumab Deruxtecan)", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"],Â 
Â  Â  Â "rationale": "æ¨™é¶ HER2 ADCã€‚æ•‘æ´åŒ–ç™‚ç©©å®šå¾Œä¹‹ç²¾æº–ç¶­æŒé¦–é¸ã€‚è¶…é«˜ DAR (8) å„ªå‹¢æ¸…é™¤ HER2 è¡¨ç¾æ®˜ç•™ç—…ç¶ï¼Œå»¶é•·ç·©è§£æ™‚é–“ã€‚",
Â  Â  Â "inclusion": ["HER2 IHC 1+/2+/3+ ç¢ºèªã€‚", "PSOC æ•‘æ´åŒ–ç™‚é”ç©©å®š (Non-PD)ã€‚", "LVEF â‰¥ 50%ã€‚"],
Â  Â  Â "exclusion": ["ILD è‚ºéƒ¨ç—…å²æˆ–ç–‘ä¼¼è‚ºéƒ¨çº–ç¶­åŒ–ã€‚"], "ref": "JCO 2024"},

Â  Â  {"cancer": "Ovarian", "name": "DOVE", "pharma": "GSK", "drug": "Dostarlimab + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"],Â 
Â  Â  Â "rationale": "é‡å°é€æ˜ç´°èƒç™Œ (OCCC)ã€‚åˆ©ç”¨ IO + anti-VEGF é›™é‡æ‰“æ“Šï¼Œæ”¹å–„å…ç–«æŠ‘åˆ¶ç’°å¢ƒï¼Œèª˜ç™¼æ‡‰ç­”ã€‚",
Â  Â  Â "inclusion": ["çµ„ç¹”å­¸ OCCC > 50%ã€‚", "é‰‘é¡æŠ—è—¥æ€§ (PFI < 12m)ã€‚"],
Â  Â  Â "exclusion": ["å…ˆå‰ç”¨éä»»ä½•å…ç–«æ²»ç™‚ (PD-1/L1)ã€‚"], "ref": "JCO 2025"},

Â  Â  {"cancer": "Cervical", "name": "innovaTV 301", "pharma": "Seagen", "drug": "Tisotumab Vedotin (Tivdak)", "pos": "R-TX", "sub_pos": ["Recurrent / Metastatic"],Â 
Â  Â  Â "rationale": "æ¨™é¶ Tissue Factor (TF) ADCã€‚æ­è¼‰ MMAE è¼‰è·ï¼Œæ—¨åœ¨å…‹æœå¾Œç·šå­å®®é ¸ç™ŒåŒ–ç™‚è€è—¥æ€§ï¼Œæ”¹å–„ OSã€‚",
Â  Â  Â "inclusion": ["å¾©ç™¼/è½‰ç§»å­å®®é ¸ç™Œã€‚", "å…ˆå‰æ¥å— 1â€“2 ç·šæ²»ç™‚å¾Œé€²å±•ã€‚"],
Â  Â  Â "exclusion": ["åš´é‡çœ¼ç–¾/è§’è†œç‚ã€‚", "æ´»å‹•æ€§å‡ºè¡€é¢¨éšªã€‚"], "ref": "NEJM 2024"}
]

# --- 4. å‹•æ…‹æ¨¡å‹å·¡é‚èˆ‡ AI æ¨¡å‹é¸æ“‡ ---
def get_gemini_model():
Â  Â  try:
Â  Â  Â  Â  available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
Â  Â  Â  Â  target_model = None
Â  Â  Â  Â  for m in available_models:
Â  Â  Â  Â  Â  Â  if 'gemini-1.5-flash' in m: target_model = m; break
Â  Â  Â  Â  if not target_model:
Â  Â  Â  Â  Â  Â  for m in available_models:
Â  Â  Â  Â  Â  Â  Â  Â  if 'gemini-pro' in m or 'gemini-1.5-pro' in m: target_model = m; break
Â  Â  Â  Â  if target_model: return genai.GenerativeModel(target_model)
Â  Â  except: return None

# --- 5. å´é‚Šæ¬„ ---
if 'selected_trial' not in st.session_state:
Â  Â  st.session_state.selected_trial = milestone_db[0]['name']

with st.sidebar:
Â  Â  st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰åª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
Â  Â  api_key = st.text_input("Gemini API Key", type="password")
Â  Â  with st.expander("âœ¨ ç—…æ­·æ•¸æ“šæ¯”å°", expanded=True):
Â  Â  Â  Â  p_notes = st.text_area("è¼¸å…¥æ‘˜è¦ (å«ç´°èƒå‹æ…‹/åˆ†å‹)", height=250)
Â  Â  Â  Â  if st.button("ğŸš€ é–‹å§‹åˆ†æ"):
Â  Â  Â  Â  Â  Â  if api_key and p_notes:
Â  Â  Â  Â  Â  Â  Â  Â  try:
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  genai.configure(api_key=api_key)
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  model = get_gemini_model()
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  if model:
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚åƒè€ƒå¯¦è­‰ï¼š{milestone_db} åŠé€²è¡Œä¸­ï¼š{ongoing_trials}ã€‚åˆ¤å®šéšæ®µä¸¦æä¾›è·¯å¾‘å»ºè­°ã€‚"
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  st.write(model.generate_content(prompt).text)
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  else: st.error("æ‰¾ä¸åˆ°å¯ç”¨ AI æ¨¡å‹ã€‚")
Â  Â  Â  Â  Â  Â  Â  Â  except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 6. ä¸»é é¢ï¼šå°èˆªåœ°åœ– ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 å¯¦è­‰èˆ‡æ”¶æ¡ˆæ•´åˆç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

cols = st.columns(len(guidelines_nested[cancer_type]))
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
Â  Â  with cols[i]:
Â  Â  Â  Â  st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
Â  Â  Â  Â  for sub in stage['subs']:
Â  Â  Â  Â  Â  Â  st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
Â  Â  Â  Â  Â  Â Â 
Â  Â  Â  Â  Â  Â  # A. é¡¯ç¤ºå¯¦è­‰é‡Œç¨‹ç¢‘ (ğŸ“š)
Â  Â  Â  Â  Â  Â  rel_milestones = [m for m in milestone_db if m["cancer"] == cancer_type and m["pos"] == stage["id"] and any(s in sub["title"] for s in m["sub_pos"])]
Â  Â  Â  Â  Â  Â  for m in rel_milestones:
Â  Â  Â  Â  Â  Â  Â  Â  with st.popover(f"ğŸ“š {m['name']}", use_container_width=True):
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  st.success(f"**ä»‹å…¥:** {m['drug']}\n\n**è©³ç´°æ•¸æ“š:** {m['summary']}")
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  if st.button("ğŸ“Š è©³ç´°ç´°ç¯€è¨è«–", key=f"btn_milestone_{m['name']}"):
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  st.session_state.selected_trial = m['name']
Â  Â  Â  Â  Â  Â Â 
Â  Â  Â  Â  Â  Â  # B. é¡¯ç¤ºæ‹›å‹Ÿä¸­ (ğŸ“)
Â  Â  Â  Â  Â  Â  rel_trials = [t for t in ongoing_trials if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
Â  Â  Â  Â  Â  Â  for t in rel_trials:
Â  Â  Â  Â  Â  Â  Â  Â  label = f"ğŸ“ {t['pharma']} | {t['name']} | {t['drug']}"
Â  Â  Â  Â  Â  Â  Â  Â  ukey = f"btn_ongoing_{t['name']}_{stage['id']}_{sub['title'].replace(' ', '')}"
Â  Â  Â  Â  Â  Â  Â  Â  with st.popover(label, use_container_width=True):
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  if st.button("ğŸ“Š é–‹å•Ÿæ·±åº¦åˆ†æå ±å‘Š", key=ukey):
Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  st.session_state.selected_trial = t['name']
Â  Â  Â  Â  Â  Â  st.markdown("</div>", unsafe_allow_html=True)
Â  Â  Â  Â  st.markdown("</div>", unsafe_allow_html=True)

# --- 7. æ·±åº¦æ•¸æ“šçœ‹æ¿ ---
st.divider()
all_list = milestone_db + ongoing_trials
try: t = next(it for it in all_list if it["name"] == st.session_state.selected_trial)
except: t = all_list[0]

st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦æ•¸æ“šåˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

if "summary" in t: # é‡Œç¨‹ç¢‘
Â  Â  r1, r2 = st.columns([1, 1])
Â  Â  with r1:
Â  Â  Â  Â  st.markdown("<div style='background:#ECEFF1; border-left:10px solid #455A64; padding:15px; border-radius:10px;'><b>ğŸ“ˆ å¯¦è­‰æ‘˜è¦ (Milestone)</b></div>", unsafe_allow_html=True)
Â  Â  Â  Â  st.write(f"**è—¥ç‰©é…æ–¹:** {t['drug']}")
Â  Â  Â  Â  st.success(t['summary'])
Â  Â  with r2:
Â  Â  Â  Â  st.markdown("<div style='background:#FFF8E1; border-left:10px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ’¡ è‡¨åºŠè§£æèˆ‡ç´°ç¯€</b></div>", unsafe_allow_html=True)
Â  Â  Â  Â  st.info(t.get('details', 'è©³è¦‹ç ”ç©¶å…¨æ–‡å ±å‘Šã€‚'))
else: # æ‹›å‹Ÿä¸­
Â  Â  r1, r2 = st.columns([1.3, 1])
Â  Â  with r1:
Â  Â  Â  Â  st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Rationale & Protocol (æ©Ÿè½‰èˆ‡çµ¦è—¥)</b></div>", unsafe_allow_html=True)
Â  Â  Â  Â  st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
Â  Â  Â  Â  st.write(f"**çµ¦è—¥ç´°ç¯€:** {t.get('dosing', 'è©³è¦‹æ‹›å‹Ÿç´°å‰‡')}")
Â  Â  Â  Â  st.success(t['rationale'])
Â  Â  Â  Â Â 
Â  Â  with r2:
Â  Â  Â  Â  st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
Â  Â  Â  Â  for inc in t.get('inclusion', []): st.write(f"â€¢ **{inc}**")
Â  Â  Â  Â  st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px; margin-top:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
Â  Â  Â  Â  for exc in t.get('exclusion', []): st.write(f"â€¢ **{exc}**")
st.markdown("</div>", unsafe_allow_html=True)
